Trademarkia Logo

Canada

C$
PROTHENA
ADVERTISED

on 5 Feb 2025

Last Applicant/ Owned by

Prothena Corporation, plc

Upper George's StreetAdelphi PlazaDún LaoghaireDublin, A96T927

IE

Serial Number

2134033 filed on 16th Sept 2021

Correspondent Address

OSLER, HOSKIN & HARCOURT LLP

Suite 320, World Exchange Plaza100 Queen StreetOttawa,

ONTARIO

CA

K1P1J9

PROTHENA

Trademark usage description

biopharmaceuticals and pharmaceuticals for the prevention, treatment, management, diagnosis and prognosis of the following specific list of enumerated Read More

Classification Information


Class [005]
Biopharmaceuticals and pharmaceuticals for the prevention, treatment, management, diagnosis and prognosis of the following specific list of enumerated indications: autoimmune, metastatic, hematologic, oncologic, ocular and neurologic diseases, conditions and disorders, and diseases, conditions and disorders associated with misfolded proteins, and diseases, conditions and disorders affecting the central nervous system, and psoriasis, psoriatic arthritis, rheumatoid arthritis, dermatitis, host/graft rejections, Alzheimer's and Parkinson's-disease associated neuropsychiatric disorders, insulin resistance, metabolic syndrome and diabetes.


Classification kind code

11

Class [042]
Research services in the field of biotechnology.


Classification kind code

11

Mark Details


Serial Number

2134033

Mark Type

Trademark

Legal History


Action TakenStatus
Submitted for opposition 42
on 5th Feb 2025
Advertised
Submitted for opposition 27
on 7th Jan 2025
Approval Notice Sent
Submitted for opposition 26
on 7th Jan 2025
Approved
Submitted for opposition 22
on 27th Dec 2024
Search Recorded
Submitted for opposition 287
on 8th Jul 2022
Pre-Assessment Letter Sent
Submitted for opposition 30
on 16th Sept 2021
Filed
Submitted for opposition 1
on 16th Sept 2021
Created
Submitted for opposition 31
on 16th Sept 2021
Formalized